204 related articles for article (PubMed ID: 32285316)
1. Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer.
Cho YH; Choi MG; Kim DH; Choi YJ; Kim SY; Sung KJ; Lee JC; Kim SY; Rho JK; Choi CM
Target Oncol; 2020 Apr; 15(2):241-247. PubMed ID: 32285316
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non-small cell lung cancer.
Choi MG; Kim YJ; Lee JC; Rho JK; Choi CM
Thorac Cancer; 2020 Nov; 11(11):3337-3345. PubMed ID: 33017518
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer.
Lin M; Liang SZ; Shi J; Niu LZ; Chen JB; Zhang MJ; Xu KC
Immunol Lett; 2017 Nov; 191():10-15. PubMed ID: 28916277
[TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.
Lin M; Liang SZ; Wang XH; Liang YQ; Zhang MJ; Niu LZ; Chen JB; Li HB; Xu KC
Immunol Res; 2017 Aug; 65(4):880-887. PubMed ID: 28508945
[TBL] [Abstract][Full Text] [Related]
5. The circulating pool of functionally competent NK and CD8+ cells predicts the outcome of anti-PD1 treatment in advanced NSCLC.
Mazzaschi G; Facchinetti F; Missale G; Canetti D; Madeddu D; Zecca A; Veneziani M; Gelsomino F; Goldoni M; Buti S; Bordi P; Aversa F; Ardizzoni A; Quaini F; Tiseo M
Lung Cancer; 2019 Jan; 127():153-163. PubMed ID: 30642544
[TBL] [Abstract][Full Text] [Related]
6. Adoptive immunotherapy for non-small cell lung cancer by NK and cytotoxic T lymphocytes mixed effector cells: retrospective clinical observation.
Zhang G; Zhao H; Wu J; Li J; Xiang Y; Wang G; Wu L; Jiao S
Int Immunopharmacol; 2014 Aug; 21(2):396-405. PubMed ID: 24881900
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Pircher A; Gamerith G; Amann A; Reinold S; Popper H; Gächter A; Pall G; Wöll E; Jamnig H; Gastl G; Wolf AM; Hilbe W; Wolf D
Lung Cancer; 2014 Jul; 85(1):81-7. PubMed ID: 24780112
[TBL] [Abstract][Full Text] [Related]
8. A trial of autologous ex vivo-expanded NK cell-enriched lymphocytes with docetaxel in patients with advanced non-small cell lung cancer as second- or third-line treatment: phase IIa study.
Yang YJ; Park JC; Kim HK; Kang JH; Park SY
Anticancer Res; 2013 May; 33(5):2115-22. PubMed ID: 23645763
[TBL] [Abstract][Full Text] [Related]
9. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.
Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H
JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint blockade as a potential therapeutic target in non-small cell lung cancer.
Yang J; Chen J; Wei J; Liu X; Cho WC
Expert Opin Biol Ther; 2016 Oct; 16(10):1209-23. PubMed ID: 27426430
[TBL] [Abstract][Full Text] [Related]
11. Expansion of natural killer (NK) and natural killer-like T (NKT)-cell populations derived from patients with B-chronic lymphocytic leukemia (B-CLL): a potential source for cellular immunotherapy.
Guven H; Gilljam M; Chambers BJ; Ljunggren HG; Christensson B; Kimby E; Dilber MS
Leukemia; 2003 Oct; 17(10):1973-80. PubMed ID: 14513047
[TBL] [Abstract][Full Text] [Related]
12. Radiochemotherapy combined with NK cell transfer followed by second-line PD-1 inhibition in a patient with NSCLC stage IIIb inducing long-term tumor control: a case study.
Kokowski K; Stangl S; Seier S; Hildebrandt M; Vaupel P; Multhoff G
Strahlenther Onkol; 2019 Apr; 195(4):352-361. PubMed ID: 30747241
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of chemotherapy with cytokine-induced killer cells in non-small cell lung cancer: A systematic review and meta-analysis of 32 randomized controlled trials.
Xiao Z; Wang CQ; Feng JH; Zhou MH; Wang YZ; Li NN; Sun YP; Liu SY; Yao XS; Li CW; Ma B; Ding J; Chen L
Cytotherapy; 2019 Feb; 21(2):125-147. PubMed ID: 30554868
[TBL] [Abstract][Full Text] [Related]
14. The immune response-related mutational signatures and driver genes in non-small-cell lung cancer.
Chen H; Chong W; Teng C; Yao Y; Wang X; Li X
Cancer Sci; 2019 Aug; 110(8):2348-2356. PubMed ID: 31222843
[TBL] [Abstract][Full Text] [Related]
15. Harnessing Natural Killer Cells in Non-Small Cell Lung Cancer.
Russell É; Conroy MJ; Barr MP
Cells; 2022 Feb; 11(4):. PubMed ID: 35203256
[TBL] [Abstract][Full Text] [Related]
16. NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors.
Park HR; Ahn YO; Kim TM; Kim S; Kim S; Lee YS; Kim M; Keam B; Kim DW; Heo DS
Cytotherapy; 2019 Jun; 21(6):603-611. PubMed ID: 31010733
[TBL] [Abstract][Full Text] [Related]
17. A tri-specific killer engager against mesothelin targets NK cells towards lung cancer.
Kennedy PR; Vallera DA; Ettestad B; Hallstrom C; Kodal B; Todhunter DA; Bendzick L; Hinderlie P; Walker JT; Pulkrabek B; Pastan I; Kratzke RA; Fujioka N; Miller JS; Felices M
Front Immunol; 2023; 14():1060905. PubMed ID: 36911670
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3.
Zhou X; Liu S; Liu J; Zhang Z; Mao X; Zhou H
Biochem Biophys Res Commun; 2020 Mar; 523(2):481-486. PubMed ID: 31883616
[TBL] [Abstract][Full Text] [Related]
19. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
20. Increased death and exhaustion of CD69
Wang Y; Sun Z; Du X; Yu Q; Sun C; Huang J; Wang L
PeerJ; 2023; 11():e15374. PubMed ID: 37180581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]